1.80
price up icon3.45%   0.06
 
loading
前日終値:
$1.74
開ける:
$1.75
24時間の取引高:
283.19K
Relative Volume:
0.50
時価総額:
$67.58M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+11.11%
1か月 パフォーマンス:
+1.12%
6か月 パフォーマンス:
+6.51%
1年 パフォーマンス:
-45.45%
1日の値動き範囲:
Value
$1.75
$1.845
1週間の範囲:
Value
$1.59
$1.845
52週間の値動き範囲:
Value
$1.23
$4.00

Metagenomi Inc Stock (MGX) Company Profile

Name
名前
Metagenomi Inc
Name
セクター
Healthcare (1115)
Name
電話
(510) 871-4880
Name
住所
5959 HORTON STREET, EMERYVILLE
Name
職員
124
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
MGX's Discussions on Twitter

MGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGX
Metagenomi Inc
1.80 65.33M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.15 118.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
812.27 81.61B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
422.50 53.69B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
822.94 49.49B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
176.00 37.34B 447.02M -1.18B -906.14M -6.1812

Metagenomi Inc Stock (MGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-07 開始されました H.C. Wainwright Buy
2024-05-02 ダウングレード JP Morgan Overweight → Neutral
2024-03-05 開始されました BMO Capital Markets Outperform
2024-03-05 開始されました Chardan Capital Markets Buy
2024-03-05 開始されました JP Morgan Overweight
2024-03-05 開始されました Jefferies Buy
2024-03-05 開始されました TD Cowen Outperform
2024-03-05 開始されました Wells Fargo Overweight
すべてを表示

Metagenomi Inc (MGX) 最新ニュース

pulisher
Jan 07, 2026

Is Metagenomi Inc. stock attractive after correctionHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - ulpravda.ru

Jan 07, 2026
pulisher
Jan 06, 2026

Will Metagenomi Inc. stock attract ESG investors2026 world cup usa national team final top scorers transition play group prediction expert opinion - ulpravda.ru

Jan 06, 2026
pulisher
Jan 04, 2026

Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 04, 2026
pulisher
Jan 03, 2026

Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn

Jan 03, 2026
pulisher
Jan 02, 2026

Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World

Jan 02, 2026
pulisher
Dec 31, 2025

Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World

Dec 31, 2025
pulisher
Dec 24, 2025

Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com

Dec 24, 2025
pulisher
Dec 24, 2025

Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK

Dec 24, 2025
pulisher
Dec 21, 2025

Metagenomi Earnings Notes - Trefis

Dec 21, 2025
pulisher
Dec 21, 2025

CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn

Dec 21, 2025
pulisher
Dec 20, 2025

Why analysts upgrade Metagenomi Inc. stock2025 Price Targets & High Win Rate Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Why Metagenomi Inc. stock attracts global investorsJuly 2025 Weekly Recap & Real-Time Market Trend Scan - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Metagenomi Inc. stock in correction or buying zoneMarket Risk Report & Community Shared Stock Ideas - bolumsonucanavari.com

Dec 19, 2025
pulisher
Dec 19, 2025

Is Metagenomi Inc. stock recession proofJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Metagenomi Inc. stock positioned well for digital economy2025 Technical Patterns & Expert Approved Trade Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 10, 2025

Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Australia

Dec 09, 2025
pulisher
Dec 09, 2025

Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India

Dec 09, 2025
pulisher
Dec 08, 2025

Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia

Dec 08, 2025
pulisher
Dec 08, 2025

Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia

Dec 08, 2025
pulisher
Dec 08, 2025

Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria

Dec 08, 2025
pulisher
Dec 08, 2025

Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Metagenomi general counsel Wein sells $352 in stock - Investing.com

Dec 08, 2025
pulisher
Dec 02, 2025

Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Metagenomi’s general counsel Wein sells $360 in stock - Investing.com India

Dec 02, 2025
pulisher
Dec 02, 2025

Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 01, 2025

Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi CFO Wapnick sells $2852 in shares - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan

Dec 01, 2025

Metagenomi Inc (MGX) 財務データ

Metagenomi Inc (MGX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
大文字化:     |  ボリューム (24 時間):